Genital herpes

Lancet

Volumn 370, Issue 9605, 2007, Pages 2127-2137

  Gupta, Rachna ^a   Warren, Terri ^b   Wald, Anna ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Westover Heights Clinic   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; HERPES SIMPLEX VACCINE; PENCICLOVIR; PLACEBO; VALACICLOVIR;

ANAMNESIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEVELOPED COUNTRY; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; FETOMATERNAL TRANSFUSION; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INFECTION RISK; MICROBIOLOGICAL EXAMINATION; MOTHER CHILD RELATION; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEXUAL TRANSMISSION; SEXUALITY; SOCIAL PSYCHOLOGY; TREATMENT PLANNING; VIRUS TRANSMISSION;

EID: 37349036293     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61908-4     Document Type: Review

References (128)

1. Roizman B., Knipe D., and Whitley R. Herpes simplex viruses. In: Knipe D., and Howley P. (Eds). Fields Virology. 5th edn. (2007), Lippincott Williams and Wlikins and Wlaters Kluwer, Philadelphia
2. Dolan A., Jamieson F., Cunningham C., Barnett B., and McGeoch D. The genome sequence of herpes simplex virus type 2. J Virol 72 (1998) 2010-2021
3. Corey L., and Wald A. Genital Herpes. In: Holmes K., Sparling P., Mardh P., et al. (Eds). Sexually transmitted diseases. 3rd edn. (1999), McGraw-Hill, New York 285-312
4. Freeman E., Weiss H., Glynn J., Cross P., Whitworth J., and Hayes R. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20 (2006) 73-83
5. Corey L., Wald A., Celum C., and Quinn T. The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics. J Acquir Immune Defic Syndr 35 (2004) 435-445
6. Koelle D., Abbo H., Peck A., Ziegweld K., and Corey L. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis 169 (1994) 956-961
7. Nahmias A., Lee F., and Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 69 (1990) 19-36
8. Roberts C., Pfister J., and Spear S. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 30 (2003) 797-800
9. Scoular A., Norrie J., Gillespie G., Mir N., and Carman W. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 324 (2002) 1366-1367
10. Manavi K., McMillan A., and Ogilvie M. Herpes simplex virus type 1 remains the principal cause of initial anogenital herpes in Edinburgh, Scotland. Sex Transm Dis 31 (2004) 322-324
11. Coyle P., O'Neill H., Wyatt D., McCaughey C., Quah S., and McBride M. Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland. J Clin Virol 27 (2003) 22-29
12. Buxbaum S., Geers M., Gross G., Schofer H., Rabenau H., and Doerr H. Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?. Med Microbiol Immunol 192 (2003) 177-181
13. Xu F., Sternberg M., Kottiri B., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296 (2006) 964-973
14. Halpern-Felsher B., Cornell J., Kropp R., and Tschann J. Oral versus vaginal sex among adolescents: perceptions, attitudes, and behavior. Pediatrics 115 (2005) 845-851
15. Sucato G., Wald A., Wakabayashi E., Vieira J., and Corey L. Evidence of latency and reactivation of both herpes simplex virus (HSV-1) and HSV-2 in the genital region. J Infect Dis 177 (1998) 1069-1072
16. Fleming D., McQuillan G., Johnson R., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337 (1997) 1105-1111
17. Langenberg A., Corey L., Ashley R., Leong W., and Straus S. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J of Med 341 (1999) 1432-1438
18. Mertz G., Benedetti J., Ashley R., Selke S., and Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 116 (1992) 197-202
19. Cowan F., French R., Mayaud P., et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect 79 (2003) 286-290
20. Alanen A., Kahala K., Vahlberg T., Koskela P., and Vainionpaa R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 112 (2005) 50-56
21. Gaytant M., Steegers E., van Laere M., et al. Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands. Sex Transm Dis 29 (2002) 710-714
22. Tideman R., Taylor J., Marks C., et al. Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic. Sex Transm Infect 77 (2001) 413-415
23. Lo J., Lim W., Ho D., Field P., and Cunningham A. Difference in seroprevalence of herpes simplex virus type 2 infection among antenatal women in Hong Kong and southern China. Sex Transm Infect 75 (1999) 123
24. Dan M., Sadan O., Glezerman M., Raveh D., and Samra Z. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel. Sex Transm Dis 30 (2003) 835-838
25. Patrick D., Dawar M., Cook D., Krajden M., Ng H., and Rekart M. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 28 (2001) 424-428
26. Hashido M., Lee F., Nahmias A., et al. An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect 120 (1998) 179-186
27. Nilsen A., Mwakagile D., Marsden H., Langeland N., Matre R., and Haarr L. Prevalence of, and risk factors for, HSV-2 antibodies in sexually transmitted disease patients, healthy pregnant females, blood donors and medical students in Tanzania and Norway. Epidemiol Infect 133 (2005) 915-925
28. Bodeus M., Laffineur K., Kabamba-Mukadi B., Hubinont C., Bernard P., and Goubau P. Seroepidemiology of herpes simplex type 2 in pregnant women in Belgium. Sex Transm Dis 31 (2004) 297-300
29. Carvalho M., de Carvalho S., Pannuti C., Sumita L., and de Souza V. Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil. Int J Infect Dis 3 (1998) 94-98
30. Ghebrekidan H., Ruden U., Cox S., Wahren B., and Grandien M. Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol 12 (1999) 53-64
31. Uuskula A., Nygard-Kibur M., Cowan F., et al. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Scand J Infect Dis 36 (2004) 727-732
32. Brown Z., Selke S., Zeh J., et al. Acquisition of herpes simplex virus during pregnancy. N Engl J Med 337 (1997) 509-515
33. Levett P. Seroprevalence of HSV-1 and HSV-2 in Barbados. Med Microbiol Immunol 194 (2005) 105-107
34. Suligoi B., Dorrucci M., Volpi A., Andreoni M., Zerboni R., and Rezza G. Prevalence and determinants of herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy. Sex Transm Dis 29 (2002) 665-667
35. Andreoletti L., Piednoir E., Legoff J., et al. High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients. J Clin Microbiol 43 (2005) 4215-4217
36. Dada A., Ajayi A., Diamondstone L., Quinn T., Blattner W., and Biggar R. A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex Transm Dis 25 (1998) 237-242
37. Russell D., Tabrizi S., Russell J., and Garland S. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol 22 (2001) 305-313
38. Ramaswamy M., Sabin C., McDonald C., Smith M., Taylor C., and Geretti A. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons. Sex Transm Dis 33 (2006) 96-101
39. Chen X., Yin Y., Liang G., et al. Sexually transmitted infections among female sex workers in Yunnan, China. AIDS Patient Care STDS 19 (2005) 853-860
40. Meyer J., Crosby R., Whittington W., et al. The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic. Sex Transm Infect 81 (2005) 309-315
41. Kim O., Kim S., Park M., et al. Seroprevalence of sexually transmitted viruses in Korean populations including HIV-seropositive individuals. Int J STD AIDS 14 (2003) 46-49
42. Da Rosa-Santos O., Goncalves Da Silva A., and Pereira Jr. A. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey. Int J Dermatol 35 (1996) 794-796
43. Limpakarnjanarat K., Mastro T., Saisorn S., et al. HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sex Transm Infect 75 (1999) 30-35
44. Rabenau H., Buxbaum S., Preiser W., Weber B., and Doerr H. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol 190 (2002) 153-160
45. Uribe-Salas F., Conde-Glez C., Juarez-Figueroa L., and Hernandez-Castellanos A. Socio-demographic characteristics and sex practices related to herpes simplex virus type 2 infection in Mexican and Central American female sex workers. Epidemiol Infect 131 (2003) 859-865
46. Mbopi-Keou F., Gresenguet G., Mayaud P., et al. Interactions between Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Type 1 Infection in African Women: Opportunities for Intervention. J Infect Dis 182 (2000) 1090-1096
47. Qutub M., and Akhter J. Epidemiology of genital herpes (HSV-2) among brothel based female sex workers in Bangladesh. Eur J Epidemiol 18 (2003) 903-905
48. Cowan F., Pascoe S., Barlow K., et al. Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe. AIDS 20 (2006) 261-267
49. Leone P., Fleming D., Gilsenan A., Li L., and Justus S. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Transm Dis 31 (2004) 311-316
50. Sizemore Jr. J., Lakeman F., Whitley R., Hughes A., and Hook III E. The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic. J Infect Dis 193 (2006) 905-911
51. Koutsky L., Stevens C., Holmes K., et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 326 (1992) 1539-1553
52. Langenberg A., Benedetti J., Jenkins J., Ashley R., Winter C., and Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" HSV-2 infection. Ann Intern Med 110 (1989) 882-887
53. Sizemore Jr. J., Lakeman F., Whitley R., Hughes A., and Hook III E. Historical correlates of genital herpes simplex virus type 2 infection in men attending an STD clinic. Sex Transm Infect 81 (2005) 303-305
54. Wald A., Zeh J., Selke S., et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic HSV-2 seropositive persons. N Engl J Med 342 (2000) 844-850
55. Whitley R. Herpes Simplex Viruses. In: Fields B., Knipe D., Howley P., et al. (Eds). Fields Virology. Third edn. (1996), Lippincott-Raven, Philadelphia 2297-2342
56. McAdam A., and Sharpe A. Infectious Diseases. In: Kumar V., Abbas A., and Fausto N. (Eds). Pathologic Basis of Disease. 7th edn. (2005), Elsevier Saunders, Philadelphia 343
57. Jerome K., Tait J., Koelle D., and Corey L. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol 72 (1998) 436-441
58. Koelle D., Burke R., Tigges M., et al. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J Clin Invest 91 (1993) 961-968
59. van Lint A., Ayers M., Brooks A., Coles R., Heath W., and Carbone F. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J Immunol 172 (2004) 392-397
60. Lang A., and Nikolich-Zugich J. Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection. J Immunol 174 (2005) 2919-2925
61. Brock B., Selke S., Benedetti J., Douglas J., and Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 263 (1990) 418-420
62. Wald A., Zeh J., Selke S., Ashley R., and Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333 (1995) 770-775
63. Brown Z., Benedetti J., Ashley R., et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 324 (1991) 1247-1252
64. Koelle D., Chen H., Gavin M., Wald A., Kwok W., and Corey L. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J Immunol 166 (2001) 4049-4058
65. Koelle D., Frank J., Johnson M., and Kwok W. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol 72 (1998) 7476-7483
66. Looker K., and Garnett G. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect 81 (2005) 103-107
67. Roest R., Carman W., Maertzdorf J., et al. Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. J Med Virol 73 (2004) 601-604
68. Corey L., Adams H., Brown Z., and Holmes K. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 98 (1983) 958-972
69. Lafferty W., Coombs R., Benedetti J., Critchlow C., and Corey L. Recurrences after oral and genital herpes simplex virus infection: influence of anatomic site and viral type. N Engl J Med 316 (1987) 1444-1449
70. Engelberg R., Carrell D., Krantz E., Corey L., and Wald A. Natural History of Genital Herpes Simplex Virus Type 1 Infection. Sex Transm Dis 30 (2003) 174-177
71. Benedetti J., Corey L., and Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 121 (1994) 847-854
72. Benedetti J., Zeh J., and Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 131 (1999) 14-20
73. Wald A., Zeh J., Selke S., Warren T., Ashley R., and Corey L. Genital Shedding of Herpes Simplex Virus among Men. J Infect Dis 186 suppl 1 (2002) S34-S39
74. Schacker T., Zeh J., Hu H., Hill J., and Corey L. Frequency of symptomatic and asymptomatic HSV-2 reactivations among HIV-infected men. J Infect Dis 178 (1998) 1616-1622
75. Goodell S., Quinn T., Mkrtichian E., Schuffler M., Holmes K., and Corey L. Herpes simplex virus: proctitis in homosexual men. N Engl J Med 309 (1983) 868
76. Bernstein D., Lovett M., and Bryson Y. Serologic analysis of first episode nonprimary genital herpes simplex virus infection. Am J Med 77 (1984) 1055-1060
77. Ashley R., and Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 12 (1999) 1-8
78. CDC. Sexually Transmitted Diseases Treatment Guidelines 2002. MMWR Morb Mortal Wkly Rep 51 (2002) 12-17
79. Lafferty W., Krofft S., Remington M., et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high prevalence population. J Clin Microbiol 25 (1987) 323-326
80. Filen F., Strand A., Allard A., Blomberg J., and Herrmann B. Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sex Transm Dis 31 (2004) 331-336
81. Ramaswamy M., McDonald C., Smith M., et al. Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect 80 (2004) 406-410
82. Ashley R. Performance and use of HSV type-specific serology test kits. Herpes 9 (2002) 38-45
83. Krantz I., Lowhagen G., Ahlberg B., and Nilstun T. Ethics of screening for asymptomatic herpes virus type 2 infection. BMJ 329 (2004) 618-621
84. Golden M., Ashley-Morrow R., Swenson P., Hogrefe W., Handsfield H., and Wald A. Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex Transm Dis 32 (2005) 771-777
85. Ashley-Morrow R., Nollkamper J., Robinson N., Bishop N., and Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 10 (2004) 530-536
86. Zimet G., Rosenthal S., Fortenberry J., et al. Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults. Sex Transm Dis 31 (2004) 665-669
87. Crosby R., DiClemente R., Wingood G., and Rose E. Testing for HSV-2 infection among pregnant teens: implications for clinical practice. J Pediatr Adolesc Gynecol 16 (2003) 39-41
88. Vonau B., Low-Beer N., Barton S., and Smith J. Antenatal serum screening for genital herpes: a study of knowledge and attitudes of women at a central London hospital. Br J Obstet Gynaecol 104 (1997) 347-349
89. Edmiston N., O'Sullivan M., Charters D., Chuah J., and Pallis L. Study of knowledge of genital herpes infection and attitudes to testing for genital herpes among antenatal clinic attendees. Aust N Z J Obstet Gynaecol 43 (2003) 351-353
90. Mindel A. Psychological and psychosexual implications of herpes simplex virus infections. Scand J Infect Dis 100 Suppl (1996) 27-32
91. Diamond C., Selke S., Ashley R., Benedetti J., and Corey L. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis 26 (1999) 221-225
92. Cherpes T., Meyn L., and Hillier S. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis 32 (2005) 84-89
93. Lafferty W., Downey L., Celum C., and Wald A. Herpes Simplex Virus Type 1 as a Cause of Genital Herpes: Impact on Surveillance and Prevention. J Infect Dis 181 (2000) 1454-1457
94. Link B., and Phelan J. Stigma and its public health implications. Lancet 367 (2006) 528-529
95. Rosenthal S., and Ebel C. A Clearer Perspective on Genital Herpes Stigma. Herpes 11 (2004) 3
96. Miyai T., Turner K., Kent C., and Klausner J. The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2. Sex Transm Dis 31 (2004) 517-521
97. ASHA. Herpes support groups (2006), American Social Health Association. http://www.ashastd.org/herpes/herpes_comm_support.cfm (accessed Jan 26, 2006).
98. Corey L., and Holmes K. Genital herpes simplex virus infection: current concepts in diagnosis, therapy and prevention. Ann Intern Med 98 (1983) 973-983
99. Fife K., Crumpacker C., Mertz G., Hill E., Boone G., and the Acyclovir Study Group. Recurrence and resistance patterns of herpes simplex virus following cessation of >6 years of chronic suppression with acyclovir. J Infect Dis 169 (1994) 1338-1341
100. Aoki F., Tyring S., Diaz-Mitoma F., Gross G., Gao J., and Hamed K. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 42 (2006) 8-13
101. Wald A., Carrell D., Remington M., Kexel E., Zeh J., and Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 34 (2002) 944-948
102. Leone P., Trottier S., and Miller J. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 34 (2002) 958-962
103. Goldberg L., Kaufman R., Kurtz T., Conant M., Eron L., and Batenhorst R. Long-term suppression of recurrent genital herpes with acyclovir: a 5-year benchmark. Arch Dermatol 129 (1993) 582-587
104. Corey L., Wald A., Patel R., et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350 (2004) 11-20
105. Patel R., Tyring S., Strand A., Price M., and Grant D. Impact of suppressive antiviral therapy on the health-related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 75 (1999) 398-402
106. Romanowski B., Aoki F., Martel A., Lavender E., Parsons J., and Saltzman R. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group [In Process Citation]. AIDS 14 (2000) 1211-1217
107. Gupta R., Hill E., McClernon D., et al. Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women. J Infect Dis 192 (2005) 1102-1107
108. Bacon T., Levin M., Leary J., Sarisky R., and Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 16 (2003) 114-128
109. Wald A., Langenberg A., Link K., et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 285 (2001) 3100-3106
110. Gottlieb S., Douglas Jr. J., Foster M., et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 190 (2004) 1059-1067
111. Wald A., Langenberg A., Krantz E., et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 143 (2005) 707-713
112. Keller M., Tuyama A., Carlucci M., and Herold B. Topical microbicides for the prevention of genital herpes infection. J Antimicrob Chemother 55 (2005) 420-423
113. Keller M., Zerhouni-Layachi B., Cheshenko N., et al. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. J Infect Dis 193 (2006) 27-35
114. Stanberry L., Spruance S., Cunningham A., et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 347 (2002) 1652-1661
115. Straus S., Wald A., Kost R., et al. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J Infect Dis 176 (1997) 1129-1134
116. Gupta R., Wald A., Krantz E., et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 190 (2004) 1374-1381
117. Sacks S. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial. J Infect Dis 189 (2004) 1341-1347
118. Kimberlin D. Neonatal herpes simplex infection. Clin Microbiol Rev 17 (2004) 1-13
119. Nahmias A., Josey W., Naib Z., Freeman M., Fernandez R., and Wheeler J. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 110 (1971) 825-837
120. Whitley R., Nahmias A., Visintine A., Fleming C., and Alford C. The natural history of genital herpes simplex virus infection of mother and newborn. Pediatrics 66 (1980) 489
121. Brown Z., Wald A., Morrow R., Selke S., Zeh J., and Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289 (2003) 203-209
122. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004, Gynecologic herpes simplex virus infections. Obstet Gynecol 104 (2004) 1111-1118
123. Sheffield J., Hollier L., Hill J., Stuart G., and Wendel G. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 102 (2003) 1396-1403
124. Schacker T., Ryncarz A., Goddard J., Shaughnessy M., and Corey L. Frequent recovery of HIV from genital herpes simplex virus lesions in HIV infected persons. JAMA 280 (1998) 61-66
125. Gadkari D., Quinn T., Gangakhedkar R., et al. HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India. J Acquir Immune Defic Syndr Hum Retrovirol 18 (1998) 277-281
126. Heng M., Heng S., and Allen S. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex viurs-1. Lancet 343 (1994) 255-258
127. Moriuchi M., Moriuchi H., Williams R., and Straus S. Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. Virology 278 (2000) 534-540
128. Colaco S., Kasper R., Tsang M., and Berger T. Dermatology Glossary: Herpes Simplex. http://missinglink.ucsf.edu/lm/DermatologyGlossary/herpes_simplex.html UCSF School of Medicine, 2003.